BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10329021)

  • 1. Reducing cytotoxicity induced by Sindbis viral vectors.
    Sawai K; Ikeda H; Ishizu A; Meruelo D
    Mol Genet Metab; 1999 May; 67(1):36-42. PubMed ID: 10329021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J; Frolov I; Russell SJ
    J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Part I. Bcl-2 and Bcl-x(L) limit apoptosis upon infection with alphavirus vectors.
    Mastrangelo AJ; Hardwick JM; Bex F; Betenbaugh MJ
    Biotechnol Bioeng; 2000 Mar; 67(5):544-54. PubMed ID: 10649229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system.
    Altman-Hamamdzic S; Groseclose C; Ma JX; Hamamdzic D; Vrindavanam NS; Middaugh LD; Parratto NP; Sallee FR
    Gene Ther; 1997 Aug; 4(8):815-22. PubMed ID: 9338010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mutations in a Sindbis virus variant able to establish persistent infection in BHK cells: the importance of a mutation in the nsP2 gene.
    Dryga SA; Dryga OA; Schlesinger S
    Virology; 1997 Feb; 228(1):74-83. PubMed ID: 9024811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-specific transfection of choriocarcinoma cells by using Sindbis virus hCG expressing chimeric vector.
    Sawai K; Meruelo D
    Biochem Biophys Res Commun; 1998 Jul; 248(2):315-23. PubMed ID: 9675133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
    Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
    J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene.
    Levine B; Huang Q; Isaacs JT; Reed JC; Griffin DE; Hardwick JM
    Nature; 1993 Feb; 361(6414):739-42. PubMed ID: 8441470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Bad-mediated apoptosis by Sindbis virus infection: involvement of pro-survival members of the Bcl-2 family.
    Moriishi K; Koura M; Matsuura Y
    Virology; 2002 Jan; 292(2):258-71. PubMed ID: 11878929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of Sindbis virus vectors produced with a chimeric split helper system.
    Ketola A; Schlesinger S; Wahlfors J
    Int J Mol Med; 2005 Jun; 15(6):999-1003. PubMed ID: 15870906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of virus-induced neuronal apoptosis by Bax.
    Lewis J; Oyler GA; Ueno K; Fannjiang YR; Chau BN; Vornov J; Korsmeyer SJ; Zou S; Hardwick JM
    Nat Med; 1999 Jul; 5(7):832-5. PubMed ID: 10395331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiapoptosis chemicals prolong productive lifetimes of mammalian cells upon Sindbis virus vector infection.
    Mastrangelo AJ; Zou S; Hardwick JM; Betenbaugh MJ
    Biotechnol Bioeng; 1999 Nov; 65(3):298-305. PubMed ID: 10486128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 VPU protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilization.
    González ME; Carrasco L
    Virology; 2001 Jan; 279(1):201-9. PubMed ID: 11145902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions.
    Figueroa B; Chen S; Oyler GA; Hardwick JM; Betenbaugh MJ
    Biotechnol Bioeng; 2004 Mar; 85(6):589-600. PubMed ID: 14966800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antitumor activity of Sindbis viral vectors.
    Tseng JC; Levin B; Hirano T; Yee H; Pampeno C; Meruelo D
    J Natl Cancer Inst; 2002 Dec; 94(23):1790-802. PubMed ID: 12464651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
    Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A.
    Ohno K; Sawai K; Iijima Y; Levin B; Meruelo D
    Nat Biotechnol; 1997 Aug; 15(8):763-7. PubMed ID: 9255791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of Bcl-2 and Bax expression in cells infected with virulent and nonvirulent strains of sindbis virus.
    Appel E; Katzoff A; Ben-Moshe T; Kazimirsky G; Kobiler D; Lustig S; Brodie C
    Virology; 2000 Oct; 276(2):238-42. PubMed ID: 11040115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alphavirus cDNA-based expression vectors: effects of RNA transcription and nuclear export.
    Boorsma M; Saudan P; Pfruender H; Bailey JE; Schlesinger S; Renner WA; Bachmann MF
    Biotechnol Bioeng; 2003 Mar; 81(5):553-62. PubMed ID: 12514804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.